Good News, HapMap: We Still Need You

Apr 23, 2009

Dan Koboldt has a blog post at MassGenomics about how HapMap data is still useful, despite concerns that it would be made obsolete by the 1,000 Genomes Project.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Recent Headlines from
Precision Oncology News

Notable's Drug Sensitivity Assay IDs Rx for Blood Cancer Patients When NGS Can't, Small Study Shows
Premium
Discovery of Inherited Mutation Sheds Light on Increased Cancer Risk in Brazilians
Premium
Case Study Supports Potential First-Line Use of Vitrakvi in NTRK Fusion-Positive Glioblastoma
Premium
Lantern Pharma Making Headway in Using AI to Revive Old Drugs, Develop New Compounds
Premium
Precision Oncology Trials Still Enroll Mostly White Patients Despite Initiatives, Calls to Diversify
Premium

The Scan

A Start

The Los Angeles Times reports that experts say Moderna's investigational COVID-19 vaccine results seem to be a step in the right direction, but that more testing is needed.

Just Go 'Round the CDC

The Washington Post reports a new coronavirus data reporting protocol goes around the Centers for Disease Control and Prevention.

Student Visa Directive Rescinded

The Trump Administration has reversed its policy that could have stripped international students of their visas, the New York Times says.

Cell Studies on Blood Features of Severe COVID-19 Cases, Infection-Related Phosphorylation Shifts, More

In Cell this week: proteomic and metabolomic analysis of blood from COVID-19 patients, change in phosphorylation with infection, and more.

Menu